Recombinant TNFSF4 (Oxelumab Biosimilar) anticorps
Aperçu rapide pour Recombinant TNFSF4 (Oxelumab Biosimilar) anticorps (ABIN5668178)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- Anti-OX40L [R4930 (Oxelumab)], Human IgG1, kappa
-
Specificité
- Binds to human OX40L.
-
Attributs du produit
-
Original Species of Ab: Human
Original Format of Ab: IgG1
-
Purification
- Protein A affinity purified
-
Pureté
- > 98 % as determined by SDS-PAGE
-
niveau d'endotoxine
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
-
Immunogène
- Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- This antibody binds to the co-stimulatory OX40L, inhibiting its interaction with OX40.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- TNFSF4 (Oxelumab Biosimilar)
-
Classe de substances
- Biosimilar
-
Sujet
- CD252, TNFSF4, tumor necrosis factor (TNF) superfamily member 4, OX40 ligand, OX-40L, TAX transcriptionally-activated glycoprotein 1, TXGP1, gp34
-
UniProt
- P23510
Antigène
-